Table of Contents
Definition Axiomm
Axiomm Technologies specializes in nanoemulsion formulations & surfactant systems for infused products. It serves CBD, food, confection, and additional markets. On August 13, 2002, Axiomm Technologies was acquired by Embark Health, but the terms of the transaction were not disclosed.
Axiomm Technologies sells nanotechnology that enhances the presentation of functional beverage products. Any product that contains an oil-based active ingredient (e.g. vitamins, CBD) is improved through our nanotechnology.
So, You create a nanoemulsion when oil is combined with functional ingredients and then blasted with energy or combined with a catalyst which, in both cases, causes the oil particles to split into smaller and smaller globs of oil. When made small enough, the particles disperse uniformly in water and will not separate into larger chunks of fat. Being incredibly small, the particles can also be absorbed where they usually aren’t (e.g. stomach lining), which lets your body absorb extra of the ingredient.
Axiomm is the only collection whose technology has been validated by all three essential manufacturers of consumption nanotechnology equipment. Our solution is simple, accessible, and genuinely best-in-class.
Axiomm Technologies Key Metrics
Founded Year:- 2006
Location:- Calgary, Alberta, Canada
Company Stage:- Acquired
Tracxn Score:- 16/100
Competitive Performance:- Ranked 77th among 182 competitors
Axiomm Capabilities
Axiomm Technologies sells nanotechnology that enhances the performance of functional beverage products. Any product that contains an oil-based active ingredient (e.g. vitamins, CBD) is improved through our technology. We make our internationally-recognized technology available to our customers in a simple, easy-to-use way that pushes the performance of their products to the next level.
Axiomm Our Technology in a Nutshell
You create a nanoemulsion when oil is combined with functional ingredients and then blasted with energy or combined with a catalyst which, in both cases, causes the oil particles to split into smaller and smaller globs of oil. When made small enough, the particles disperse uniformly in water and won’t separate into more giant chunks of fat. Being incredibly small, the particles can also be absorbed where they usually aren’t (e.g. stomach lining), which allows your body to absorb more of the ingredient.
Why Axiomm?
We are the only group whose technology has been validate by all three leading manufacturers of consumption nanotechnology equipment. Our solution is simple, accessible, and genuinely best-in-class. Our technologies are commercial scale and have already been stress-test in the harshest environments.
Axiomm Technologies Market
However, [Axiomm] Technologies primarily operates in the health tech market.
[Axiomm] Technologies also operates in Enterprise, Tech broad market segments.
Axiomm Technologies Funding & Investment
However, axiomm Technologies is a funded company.
Take a look at [Axiomm] Technologies Investors
Axiomm Technologies Competitors
So, [Axiomm] Technologies’ competitors include Creso Pharma, Grow Group, Avicanna, and ZYUS Life Sciences. [Axiomm] Technologies ranks 77th among 182 active competitors.
Expert Collections containing Axiomm Technologies
Expert Collections are analyst-curates lists highlighting the companies you need to know in the most critical technology spaces.
[Axiomm] Technologies is include in 1 Expert Collection, including Cannabis.
Latest Axiomm Technologies News
MMJ Group investees start capitalizing on the growing demand for cannabis products. The company is well-position to create value from its existing portfolio with a liquid balance sheet and cash flows from investments. MMJ holds warrants to make follow-on investments in existing listed and unlisted investments MMJ Group Holdings Ltd’s ( ASX: MMJ ) investee businesses are starting to capitalize on the growing demand for CBD (cannabidiol) and cannabis products in North America and Europe. So, during August, MMJ’s material investments made significant announcements in terms of achievement of business objectives and funding their operations: Harvest One (HVT) (11% of MMJ’s portfolio) Harvest One Cannabis Inc ( CVE: HVT ) completed the sale of the Duncan Facility and its related operations in line with its transition to a cannabis-focused consumer packaged goods company.
MMJ believes that the HVT share price materially undervalues the opportunities provided by its existing portfolio as the Canadian investment market recovers and provides the opportunity for investors to acquire MMJ shares at an attractive price to their intrinsic value. [Axiomm] Technologies Inc (2% of portfolio) In August 2020, Embark Health executed an agreement to acquire all of the issued capital of [Axiomm]. MMJ has completed documentation to sell its holding in [Axiomm] to Embark Health in return for Embark Health shares with a value of C$2.44 each for a total value of C$0.7 million.
Axiomm (FAQ)
Where is Axiomm Technologies’s headquarters?
[Axiomm]Technologies is located in Calgary, Alberta, Canada.
Who invested in Axiomm Technologies?
[Axiomm] Technologies is fund by HMW Capital.
How much funding has Axiomm Technologies raised to date?
[Axiomm] Technologies has raised CA$1.9M.
When was the last funding round for Axiomm Technologies?
[Axiomm] Technologies closed its last funding round on January 1, 2020, from a Private Equity round.
Who are Axiomm Technologies’ competitors?
Alternatives and possible competitors to [Axiomm] Technologies may include Air Protein, Neutral, and HempFusion.